The main purpose of this study is to see how safe the investigational drug known as LY3009120 is and whether it will work to help people with advanced cancer or cancer that has spread to other parts of the body.
Advanced or metastatic cancer Other available therapies have failed to cure the cancer The cancer that has no proven effective therapy The cancer can be biopsied (depending on the tumor type and/or the dose of drug received, tumor biopsies may be required) Able to swallow capsules
Exclusion Criteria:
Have active cancer in the brain or spinal cord Have an active infection of any kind (fungal, viral, or bacterial) Have a cancer of the blood Are pregnant or breastfeeding Have some types of eye problems or impairments
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There are 6 Locations for this study
See Locations Near You
Pinnacle Oncology Hematology Scottsdale Arizona, 85258, United States
Massachusetts General Hospital Boston Massachusetts, 02114, United States
University of Texas MD Anderson Cancer Center Houston Texas, 77030, United States
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nedlands , 6009, Australia
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Villejuif , 94805, France
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona , 08035, Spain
